Skip to main content
Premium Trial:

Request an Annual Quote

Response Biomedical CEO Resigns

NEW YORK (GenomeWeb News) – Response Biomedical late Friday announced the resignation of its CEO Wayne Kay, effective immediately. Kay also resigned as a director of the Vancouver, British Columbia-based diagnostics company.

Peter Thompson will serve as executive chairman and interim CEO, and Reponse Bio has retained an executive search firm to seek a permanent CEO.

Kay's resignation came two days after the firm announced a 17 percent increase in its second-quarter revenues. During the quarter, though, its submission to the US Food and Drug Administration for 510(k) clearance of its NTproBNP assay for the diagnosis of heart failure on its Ramp 200 platform had been turned down.

Kay had previously served as CEO of venture capital firm Kleiner Perkins Caufield & Byers, and was president and CEO of Quidel.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more